tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease
Cell Biology and Toxicology · 2024
DOI: 10.1007/s10565-024-09919-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Biology and Toxicology, 2024. Verfasst von Di Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong, 226001, China. Hauptthemen laut MEDLINE: RNA, Transfer, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
tRNAs are codon decoders that convert the transcriptome into the proteome. The field of tRNA research is excited by the increasing discovery of specific tRNA modifications that are installed at specific, evolutionarily conserved positions by a set of specialized tRNA-modifying enzymes and the biogenesis of tRNA-derived regulatory fragments (tsRNAs) which exhibit copious activities through multiple mechanisms. Dysregulation of tRNA modification usually has pathological consequences, a phenomenon referred to as "tRNA modopathy". Current evidence suggests that certain tRNA-modifying enzymes and tsRNAs may serve as promising diagnostic biomarkers and therapeutic targets, particularly for chemoresistant cancers. In this review, we discuss the latest discoveries that elucidate the molecular mechanisms underlying the functions of clinically relevant tRNA modifications and tsRNAs, with a focus on malignancies. We also discuss the therapeutic potential of tRNA/tsRNA-based therapies, aiming to provide insights for the development of innovative therapeutic strategies. Further efforts to unravel the complexities inherent in tRNA biology hold the promise of yielding better biomarkers for the diagnosis and prognosis of diseases, thereby advancing the development of precision medicine for health improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong, 226001, China.
- College of Animal Science and Technology, Henan Agricultural University, Zhengzhou, 450046, China.
- Research Center for Animal Husbandry, National Research and Innovation Agency, Jakarta Pusat, 10340, Indonesia.
- College of Veterinary Medicine, Northwest A&F University, Yangling, 712100, China.
- Faculty of Animal and Agricultural Sciences, Universitas Diponegoro, Semarang, 1269, Indonesia.
- Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong, 226001, China. goodlife.huang@ntu.edu.cn.
Förderung
- Natural Science Foundation of the Higher Education Institutions of Jiangsu Province
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Wu, D., Li, X., Khan, F. A., Yuan, C., Pandupuspitasari, N. S., Huang, C., Sun, F., & Guan, K. (2024). tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-024-09919-9
Vancouver
Wu D, Li X, Khan FA, Yuan C, Pandupuspitasari NS, Huang C, et al. tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease. Cell Biology and Toxicology. 2024. doi:10.1007/s10565-024-09919-9
BibTeX
@article{Wu2024,
author = {Wu, Di and Li, Xiuling and Khan, Faheem Ahmed and Yuan, Chenyang and Pandupuspitasari, Nuruliarizki Shinta and Huang, Chunjie and Sun, Fei and Guan, Kaifeng},
title = {tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease},
journal = {Cell Biology and Toxicology},
year = {2024},
doi = {10.1007/s10565-024-09919-9}
}
EUVIMED